Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.45 |
| ▸ | FDPS | P14324 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9470459 | 0.93 | CYP3A4 (0.53) | CYP3A4L3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL28239735 | 0.89 | CYP3A4 (0.50) | CYP3A4L3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL27593423 | 0.89 | CYP3A4 (0.55) | CYP3A4L3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL28290217 | 0.89 | CYP3A4 (0.50) | CYP3A4L3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL28812223 | 0.87 | CYP3A4 (0.48) | CYP3A4L3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL28111896 | 0.86 | TRPM8 (0.57) | CYP3A4L3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL28285814 | 0.86 | TRPM8 (0.57) | CYP3A4L3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL28208605 | 0.84 | CYP3A4 (0.46) | CYP3A4L3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL27613222 | 0.84 | CYP3A4 (0.53) | CYP3A4L3MBTL1ALDH1A1TDP1TSHR | |
| SCHEMBL10910293 | 0.82 | CYP3A4 (0.41) | CYP3A4L3MBTL1ALDH1A1TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4108706-B1 | METHOD FOR PRODUCING CYCLIC POLYSILOXANE | SHINETSU CHEMICAL CO (JP) | 2025-09-10 | — | — | EP | claimed |
| CN-119241353-A | Method for extracting alpha-ketoglutaric acid from fermentation liquor | 浙江大学 | 2025-01-03 | — | — | CN | claimed |
| CN-115135698-B | Process for producing cyclic polysiloxane | 信越化学工业株式会社 | 2024-04-26 | — | — | CN | claimed |
| US-20230095953-A1 | METHOD FOR PRODUCING CYCLIC POLYSILOXANE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-03-30 | — | — | US | claimed |
| EP-4108706-A1 | METHOD FOR PRODUCING CYCLIC POLYSILOXANE | Shin-Etsu Chemical Co., Ltd. (JP) | 2022-12-28 | — | — | EP | claimed |
| CN-115135698-A | Method for producing cyclic polysiloxane | 信越化学工业株式会社 | 2022-09-30 | — | — | CN | claimed |
| EP-4022653-A2 | SYSTEMS AND METHODS FOR SELECTIVE RECOVERY OF METALS FROM ION EXCHANGE RESINS | CF Technologies, Inc. (US) | 2022-07-06 | — | — | EP | claimed |
| EP-3736306-B1 | RECOVERY OF FIBERS FROM FIBER REINFORCED POLYMERS WITH LEWIS BASES | BOEING CO (US) | 2022-04-13 | — | — | EP | claimed |
| US-11208345-B2 | Recovery of fibers from fiber reinforced polymers with Lewis bases | THE BOEING COMPANY (US) | 2021-12-28 | — | — | US | claimed |
| US-11167451-B2 | Lewis base-mediated recovery of fibers from fiber reinforced polymers | THE BOEING COMPANY (US) | 2021-11-09 | — | — | US | claimed |
| US-20180086639-A1 | Recovery of Fibers from Fiber Reinforced Polymers with Lewis Bases | THE BOEING COMPANY | 2018-03-29 | — | — | US | claimed |
| US-8178585-B2 | Solvent-free synthesis of soluble nanocrystals | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2012-05-15 | — | — | US | claimed |
| US-20110006269-A1 | SOLVENT-FREE SYNTHESIS OF SOLUBLE NANOCRYSTALS | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2011-01-13 | — | — | US | claimed |
| EP-2227319-A2 | SOLVENT-FREE SYNTHESIS OF SOLUBLE NANOCRYSTALS | Advanced Technology Materials, Inc. (US) | 2010-09-15 | — | — | EP | claimed |
| WO-2009065010-A2 | SOLVENT-FREE SYNTHESIS OF SOLUBLE NANOCRYSTALS | ADVANCED TECHNOLOGY MATERIALS, INC. (US) | 2009-05-22 | — | — | WO | claimed |
| CN-1606431-A | Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes | DU PONT (US) | 2005-04-13 | — | — | CN | claimed |
| US-4574072-A | Method for extracting lanthanides and actinides from acid solutions by modification of purex solvent | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1986-03-04 | — | — | US | claimed |
| US-4483801-A | SULFONATING TRIARYLPHOSPHINE, HUDROLYSIS, AND SOLVENT EXTRACTION | RHONE-POULENC CHIMIE DE BASE (FR) | 1984-11-20 | — | — | US | claimed |
| US-4219607-A | High voltage insulating compositions containing phosphorus compounds | RAYCHEM CORPORATION (US) | 1980-08-26 | — | — | US | claimed |
| US-4022721-A | ISOCYANATE AND EPOXY COMPOUNDS | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) | 1977-05-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230095953-A1 | METHOD FOR PRODUCING CYCLIC POLYSILOXANE | POLL, PCNA, RPN1 | CYP3A4 2809/4885L3MBTL1 2237/4885ALDH1A1 4080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.